Valutazione della funzione uditiva nella beta-talassemia omozigote.

Translated title of the contribution: Evaluation of auditory function in homozygous beta-thalassemia

M. Stura, R. Arigliani, A. C. Molinari, V. Tarantino

Research output: Contribution to journalArticlepeer-review


We examined the auditory function of 29 subjects affected by homozygous beta-thalassemia, managed with an high transfusion scheme and regularly treated with 40-60 mg/kg/day of desferrioxamine. A group of 29 healthy subjects is studied as control. We found conductive hearing defect in 8 thalassemics (6 bilateral) and sensory-neural hearing loss at high frequencies in 4. Thalassemic patients showed more auditory impairment than controls, an higher incidence of tonsillar hypertrophy, adenotonsillitis and submandibular lymph-node enlargement.

Translated title of the contributionEvaluation of auditory function in homozygous beta-thalassemia
Original languageItalian
Pages (from-to)703-705
Number of pages3
JournalPediatria Medica e Chirurgica
Issue number5
Publication statusPublished - Sep 1986

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Evaluation of auditory function in homozygous beta-thalassemia'. Together they form a unique fingerprint.

Cite this